Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry.
Yong Hoon KimAe-Young HerMyung Ho JeongByeong-Keuk KimSung-Jin HongDong-Ho ShinJung-Sun KimYoung-Guk KoDonghoon ChoiMyeong-Ki HongYangsoo JangPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2019)
The BB + ACEI group demonstrated reduced cumulative incidences of MACE, all-cause death, cardiac death, TVR, and TVF compared with the BB + ARB group in patients with AMI who underwent successful PCI with DES during a 2-year follow-up period.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- left ventricular
- growth factor
- coronary artery disease
- st segment elevation myocardial infarction
- acute coronary syndrome
- st elevation myocardial infarction
- recombinant human
- antiplatelet therapy
- angiotensin ii
- atrial fibrillation
- angiotensin converting enzyme